Alessio Massironi

Dr. Alessio Massironi

alessio.massironi@unimi.it
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
AMAlessio Massironi
Alessio Massironi
AMAndrea Morelli
Andrea Morelli
LGLucia Grassi
Lucia Grassi
Dario PuppiDario Puppi
Dario Puppi
SBSimona Braccini
Simona Braccini
Federica ChielliniFederica Chiellini
Federica Chiellini

20 October 2023 in Gels
Verified
Journal Article
Open access
PDF file
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
AMAlessio Massironi
Alessio Massironi
MSMichela Sugni
Michela Sugni
MEMatthew Ensign
Matthew Ensign
Stefania MARZORATIStefania MARZORATI
Stefania MARZORATI
MFMahdi Forouharshad
Mahdi Forouharshad
In this review, we focused on recent efforts in the design and development of materials with biomimetic properties. Innovative methods promise to emulate cell microenvironments and tissue functions, but many aspects regarding cellular communication, motility, and responsiveness remain to be explained. We photographed the state-of-the-art advancements in biomimetics, and discussed the complexity of a “bottom-up” artificial construction of living systems, with particular highlights on hydrogels, collagen-based composites, surface modifications, and three-dimensional (3D) bioprinting applications. Fast-paced 3D printing and artificial intelligence, nevertheless, collide with reality: How difficult can it be to build reproducible biomimetic materials at a real scale in line with the complexity of living systems? Nowadays, science is in urgent need of bioengineering technologies for the practical use of bioinspired and biomimetics for medicine and clinics.

24 July 2019 in Flavour and Fragrance Journal
Verified
Journal Article
Closed access
PDF file
AMAndrea Morelli
Andrea Morelli
AMAlessio Massironi
Alessio Massironi
Dario PuppiDario Puppi
Dario Puppi
DCDonato Creti
Donato Creti
EMElia Domingo Martinez
Elia Domingo Martinez
Federica ChielliniFederica Chiellini
Federica Chiellini

Verified
Journal Article
Open access
PDF file
AMAlessio Massironi
Alessio Massironi
AFAlbina Ribeiro Franco
Albina Ribeiro Franco
PBPedro S Babo
Pedro S Babo
Dario PuppiDario Puppi
Dario Puppi
Federica ChielliniFederica Chiellini
Federica Chiellini
MGManuela E Gomes
Manuela E Gomes
Recurrent microbial infections are a major cause of surgical failure and morbidity. Wound healing strategies based on hydrogels have been proposed to provide at once a barrier against pathogen microbial colonization, as well as a favorable environment for tissue repair. Nevertheless, most biocompatible hydrogel materials are more bacteriostatic than antimicrobial materials, and lack specific action against pathogens. Silver-loaded polymeric nanocomposites have efficient and selective activity against pathogenic organisms exploitable for wound healing. However, the loading of metallic nanostructures into hydrogels represents a major challenge due to the low stability of metal colloids in aqueous environments. In this context, the aim of the present study was the development of highly stable silver nanoparticles (AgNPs) as novel potential antimicrobial agents for hyaluronic acids hydrogels. Two candidate stabilizing agents obtained from natural and renewable sources, namely cellulose nanocrystals and ulvan polysaccharide, were exploited to ensure high stability of the silver colloid. Both stabilizing agents possess inherent bioactivity and biocompatibility, as well as the ability to stabilize metal nanostructures thanks to their supramolecular structures. Silver nitrate reduction through sodium borohydride in presence of the selected stabilizing agents was adopted as a model strategy to achieve AgNPs with narrow size distribution. Optimized AgNPs stabilized with the two investigated polysaccharides demonstrated high stability in phosphate buffer saline solution and strong antimicrobial activity. Loading of the developed AgNPs into photocrosslinked methacrylated hyaluronic acid hydrogels was also investigated for the first time as an effective strategy to develop novel antimicrobial wound dressing materials.

22 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
AMAlessio Massironi
Alessio Massironi
AMAndrea Morelli
Andrea Morelli
Dario PuppiDario Puppi
Dario Puppi
Federica ChielliniFederica Chiellini
Federica Chiellini
The worldwide diffusion of nanotechnologies into products nowadays has completely revolutionized human life, providing novel comfort and benefits. Their inclusion in food and cosmetic has a heavy impact over the market, allowing the development of higher value products with enhanced properties. Natural origin polymers and in particular polysaccharides represent a versatile platform of materials for the development of micro/nanostructured additives for food and cosmetic products due to their chemical versatility, biocompatibility, and abundance. Here, we review the current applications of polysaccharides-based micro/nanostructures, taking into consideration the precursors’ production, isolation, and extraction methods and highlighting the advantages, possible drawbacks, and market diffusion.

4 March 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
NBNora Bloise
Nora Bloise
AMAlessio Massironi
Alessio Massironi
Cristina Della PinaCristina Della Pina
Cristina Della Pina
JAJenny Alongi
Jenny Alongi
SSStella Siciliani
Stella Siciliani
LVLivia Visai
Livia Visai
Gold nanoparticles are elective candidate for cancer therapy. Current efforts are devoted to developing innovative methods for their synthesis. Besides, understanding their interaction with cells have become increasingly important for their clinical application. This work aims to describe a simple approach for the synthesis of extra-small gold nanoparticles for breast cancer therapy. In brief, a biocompatible and biodegradable polyamidoamine (named AGMA1-SH), bearing 20%, on a molar basis, thiol-functionalized repeat units, is employed to stabilize and coat extra-small gold nanospheres of different sizes (2.5, 3.5, and 5 nm in gold core), and to generate a nanoplatform for the link with Trastuzumab monoclonal antibody for HER2-positive breast cancer targeting. Dynamic light scattering, transmission electron microscopy, ultraviolet visible spectroscopy, X-ray powder diffraction, circular dichroism, protein quantification assays are used for the characterization. The targeting properties of the nanosystems are explored to achieve enhanced and selective uptake of AGMA1-SH-gold nanoparticles by in vitro studies against HER-2 overexpressing cells, SKBR-3 and compared to HER-2 low expressing cells, MCF-7, and normal fibroblast cell line, NIH-3T3. In vitro physicochemical characterization demonstrates that gold nanoparticles modified with AGMA1-SH are more stable in aqueous solution than the unmodified ones. Additionally, the greater gold nanoparticles size (5-nm) is associated with a higher stability and conjugation efficiency with Trastuzumab, which retains its folding and anticancer activity after the conjugation. In particular, the larger Trastuzumab functionalized nanoparticles displays the highest efficacy (via the pro-apoptotic protein increase, anti-apoptotic components decrease, survival-proliferation pathways downregulation) and internalization (via the activation of the classical clathrin-mediated endocytosis) in HER-2 overexpressing SKBR-3 cells, without eliciting significant effects on the other cell lines. The use of biocompatible AGMA1-SH for producing covalently stabilized gold nanoparticles to achieve selective targeting, cytotoxicity and uptake is completely novel, offering an important advancement for developing new anticancer conjugated-gold nanoparticles.